In 2023, the Chinese Center for Drug Evaluation of the National Medical Products Administration (NMPA) approved 132 New Drug Applications (NDA) for biopharmaceuticals. more than 32 percent of all approvals were granted to antineoplastic drugs, while biopharmaceuticals for the treatment of blood system and endocrine system diseases were also prevalent among the approvals.
Distribution of therapeutic areas for approved biopharmaceutical New Drug Applications (NDA) in China in 2023
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
National Medical Products Administration. (April 24, 2024). Distribution of therapeutic areas for approved biopharmaceutical New Drug Applications (NDA) in China in 2023 [Graph]. In Statista. Retrieved November 21, 2024, from https://www.statista.com/statistics/1319964/china-therapeutic-for-approved-biopharmaceutical-nda/
National Medical Products Administration. "Distribution of therapeutic areas for approved biopharmaceutical New Drug Applications (NDA) in China in 2023." Chart. April 24, 2024. Statista. Accessed November 21, 2024. https://www.statista.com/statistics/1319964/china-therapeutic-for-approved-biopharmaceutical-nda/
National Medical Products Administration. (2024). Distribution of therapeutic areas for approved biopharmaceutical New Drug Applications (NDA) in China in 2023. Statista. Statista Inc.. Accessed: November 21, 2024. https://www.statista.com/statistics/1319964/china-therapeutic-for-approved-biopharmaceutical-nda/
National Medical Products Administration. "Distribution of Therapeutic Areas for Approved Biopharmaceutical New Drug Applications (Nda) in China in 2023." Statista, Statista Inc., 24 Apr 2024, https://www.statista.com/statistics/1319964/china-therapeutic-for-approved-biopharmaceutical-nda/
National Medical Products Administration, Distribution of therapeutic areas for approved biopharmaceutical New Drug Applications (NDA) in China in 2023 Statista, https://www.statista.com/statistics/1319964/china-therapeutic-for-approved-biopharmaceutical-nda/ (last visited November 21, 2024)
Distribution of therapeutic areas for approved biopharmaceutical New Drug Applications (NDA) in China in 2023 [Graph], National Medical Products Administration, April 24, 2024. [Online]. Available: https://www.statista.com/statistics/1319964/china-therapeutic-for-approved-biopharmaceutical-nda/
